Abstract
Xanthogranuloma of the sellar region is a rare clinical observation. Although it was included in the World Health Organization (WHO) brain tumor classification in 2000, its clinical features and pathogenesis remain uncertain. We report herein seven cases of xanthogranuloma of the sellar region who underwent transsphenoidal surgery at Tokyo Women’s Medical University between 2005 and 2011, and discuss the clinical characteristics of this tumor. Six out of these 7 patients (86 %) presented with endocrinological dysfunction, six (86 %) had headaches, five (71 %) had visual field disturbances, and three (43 %) had diplopia including two with unilateral ptosis. Pathological findings revealed cholesterol clefts, hemosiderin deposits, chronic inflammatory infiltrates, multinucleated giant cells, macrophages, and fibrous proliferation. Of these seven cases, components of Rathke’s cleft cyst were observed for six. Xanthogranuloma in the sellar region is suspected of being a terminal stage resulting from a secondary reaction caused by repeated inflammatory change, hemorrhage, and degeneration of a Rathke’s cleft cyst.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Xanthogranulomas (XG), known as cholesterol granulomas, which have the histologic characteristics of both granuloma and xanthoma, develop in a variety of locations, for example in the abdomen, skin, and central nervous system [1–6]. Intracranial XG, especially in the sellar region is very rare and had been regarded as a variant of adamantinomatous craniopharyngioma. Paulus et al. [7] in 1999 reported 37 XGs in the sellar region that differ from classical craniopharyngioma (CP). As a result of this report, XG of the sellar region was added to the World Health Organization (WHO) brain tumor classification in 2000 [8]. However, its natural history is still unknown. We report seven cases of XG of the sellar region and discuss their clinical, endocrinological, and pathological characteristics and possible histogenesis in relation to Rathke’s cleft cyst (RCC).
Patients and methods
Seven patients undergoing transsphenoidal surgery for XG of the sellar region at Tokyo Women’s Medical University between 2005 and 2011 were reviewed. These seven cases with xanthogranulomatous changes without typical CP and ciliated RCC were taken from our series consisting, at the moment, of 123 RCCs and 51 CPs. Surgery was performed on 4 males and 3 females. The age of the patients ranged from 12 to 68 years (average 46.6). Postoperatively the minimum and average follow-up periods for inclusion in the study were 12 and 40.3 months, respectively (Tables 1, 2). CT and MRI results were available for all patients, and anterior pituitary lobe stimulation tests were performed before and after surgery. Pituitary function was investigated by use of standardized basal and dynamic stimulation tests and was evaluated in accordance with currently accepted criteria. Visual fields were examined pre and postoperatively by use of Goldmann or Humphrey perimetry methods for patients whose optic chiasm was compressed by the mass on MRI.
All patients underwent endonasal transsphenoidal surgery. The intent of surgery was cyst decompression and removal of a specimen of its wall and adjacent fibrous tissue. Pathological investigation was also performed intra-operatively to distinguish the xanthogranuloma from CP and make a decision how much we should remove. The surgical material was fixed in 10 % buffered formalin, embedded in paraffin, and sectioned. For light microscopy, the tissues were stained with hematoxylin–eosin and Masson-trichrome stain. Immunostaining for keratin and cytokeratin was also performed in all cases.
Results
Pre-operative clinical presentation is shown in Table 1 and post-operative status in Table 2. Six of these 7 patients (86 %) presented with endocrinological dysfunction. There were effects on multiple axes (2–6 axes, average 4.3 axes) with three cases having diabetes insipidus. After surgery, one case (case 2) improved, four cases remained unchanged, except that the affected prolactin inhibiting factor-related hyper-prolactinemia normalized, and one case (case 6) deteriorated. Six patients (86 %) presented with headache; for all patients this disappeared after surgery. Five patients (71 %) had visual field disturbance, subjectively for three and objectively for two. All improved after surgery. Three patients (43 %) presented with diplopia including two cases with unilateral ptosis; all recovered after surgery. The duration of these symptoms ranged between 4 months and 11 years.
Preoperative radiological findings are shown in Table 1 and Figs. 1, 2, 3, 4, 5, 6, 7. On MRI, a wide range of signal-intensity patterns was observed for the cyst and one case was a solid mass without cyst. Tumor size was defined as the maximum preoperative tumor diameter recorded; this ranged from 12 to 32 (mean 19.1) mm. CT revealed calcification for three patients.
All patients underwent transsphenoidal surgery. Cysts contained xanthochromic fluid in two, yellow-brown mucus in two, and yellow-brown mucus with motor oil-like liquid in two. After drainage and irrigation of the cyst, cyst wall, fibrous tissue, and any solid mass were removed partially for two patients, sub-totally for two, and totally for three (Table 2).
Histopathological findings are listed in Table 3 and shown in Figs. 1, 2, 3, 4, 5, 6, 7. They revealed cholesterol clefts, hemosiderin deposits, chronic inflammatory infiltrates, multinucleated giant cells, macrophages, and fibrous proliferation. Of these seven cases, calcification was observed for five and components of RCC were observed for six.
Discussion
Xanthogranulomas in the sellar region are very rare. As a result of the scarcity of XG in the sellar region, their natural history, pathogenesis, and clinical presentation remain unclear. Paulus et al. [7] first described XG in the sellar region as a different entity from classical CP, focusing on age, radiological findings, anatomical localization, size, symptoms (marked endocrinological deficits and visual disturbances), outcome, and pathological features. Consequently, XG of the sellar region was added to the World Health Organization (WHO) brain tumor classification in 2000 as a new entity [8]. Since then we have found ten reports of XG in the sellar region [9–18], but it is still difficult to distinguish among XG in the sellar region, CP, and RCC pre-operatively and even, occasionally, post-operatively [19–22]. The reason is the overlap of features and, in some cases, transitional status.
Our seven cases of XG in the sellar region are characterized by their radiological findings, endocrinological dysfunction, pathological findings, and good outcomes. MRI findings revealed a variety of T1 and T2 intensities. They derived from the different degree of intra-cystic inflammation and amount of hemorrhage. Severe multi-axis endocrinological dysfunction was observed for six of the seven cases. This might be a consequence of inflammatory changes, similarly to RCC. One case (case 5) had normal pituitary function. The most probable reason for the absence of endocrinological dysfunction was its entirely supra sellar location, so inflammation could probably not spread to the normal gland. Histopathological studies revealed cholesterol clefts, hemosiderin deposits, chronic inflammatory infiltrates, multinucleated giant cells, macrophages, and fibrous proliferation. But a single important characteristic was that six of these seven cases had components of RCC. Six cases with headache and three cases with diplopia of these seven cases were all relieved after surgery. These symptoms may be attributed to the inflammation.
On the other hand, the incidence of RCC has increased with the widespread availability of, and advances in, MRI [23, 24]. An estimated 13–22 % of the population has incidental asymptomatic RCC at autopsy [25]. Some RCCs remain unchanged in size for long periods of time or even regress, whereas others can become sufficiently large, undergo inflammatory changes, associate with pituitary apoplexy, produce calcifications or ossify, and cause visual impairment, hypothalamic-pituitary dysfunction, and headaches. As just described, RCC has the potential to present a variety of clinicopathological features [26–41]. Although inflammation of RCC differs in degree, it is not only its severity that induces xanthogranulomatous changes. We might speculate that the RCC becomes inflamed, then bleeds, and subsequently degenerates. These interactions occur repeatedly and induce the xanthogranulomatous change.
Whether we can find the RCC’s component or not depends on the extent of surgical removal of the lesion and how RCC’s components were modified by inflammation and hemorrhage. Of these seven cases, we removed cyst wall, fibrous tissue, and any solid mass partially in two, sub-totally in two, and totally in three. There is a possibility that small components of CP might have existed in the residual lesion, and only total resection can guarantee proof of tumor origin from RCC. However, total resection may result in deterioration of pituitary function. Furthermore most of RCCs and XGs have good prognosis that does not require total removal.
In some cases, when the RCC’s components were more distinctive, diagnosis was RCC with xanthomatous change, whereas in the absence of RCC’s components, diagnosis was XG of the sellar region [7, 41]. There have, furthermore, been reports of hypophysitis and pituitary adenomas with xanthogranulomatous reaction [42–45]. Pituitary adenoma and hypophysitis sometimes coexist with RCC [46]. It is possible that the RCC’s components disappeared as a consequence of the severe inflammation and hemorrhage or were not included in the resected specimen at surgery. In fact, in three of our six cases the RCC’s components were found on a subsequent review of the specimens.
Rathke’s cleft cyst is basically a cystic mass, but many XGs without cyst have been reported, including by Paulus et al. One of our 7 cases was a solid mass without cyst. In the solid case (case 7), the solid lesion became completely ossified and SONOPET was needed to remove the ossified mass. In cases with cysts it is quite likely that the original cyst-lining epithelial lesion, presumably RCCs in most cases, had induced the xanthogranulomatous change. On the other hand, the cause of XG is ambiguous in solid cases without cysts. It was suspected that cyst content became absorbed in the prolonged course or was pressed by the granulation and disappeared. When no component of an epithelial lesion responsible for the reaction could be detected, despite radical resection, it should be termed “xanthogranuloma of the sellar lesion”.
Xanthogranulomas may occur at different intracranial and skull base sites, other than the parasellar lesion, for example petrous apex, other skull base locations, and choroid plexus [1–6]. It is unreasonable to consider that XGs associated with other lesions are also related to RCCs. There might be other primary histological structures, except RCC, as a background for inflammatory changes.
Therefore, we might speculate that a XG in the sellar region, RCC with xanthogranulomatous change, hypophysitis with xanthogranulomatous reaction, and to some extent also pituitary adenoma with xanthogranulomatous reaction have the pathological characteristics of an entity originating from RCC, with the final status resulting from the secondary changes: repeated inflammation, hemorrhage, and degeneration.
Conclusions
Xanthogranuloma of the sellar region can be differentiated from adamantinomatous CP, and its characteristics are very similar to those of Rathke’s cleft cyst with inflammatory changes. Xanthogranuloma of the sellar region is suspected to be a final stage resulting from secondary reactions caused by repeated inflammation, hemorrhage, and degeneration of Rathke’s cleft cyst.
Abbreviations
- RCC:
-
Rathke’s cleft cyst
- MRI:
-
Magnetic resonance imaging
- T1:
-
T1 weighted image
- T2:
-
T2 weighted image
- Gd:
-
Gadolinium enhancement
- TSS:
-
Transsphenoidal surgery
References
Gherini SG, Brackmann DE, Lo WW, Solti-Bohman LG (1985) Cholesterol granuloma of the petrous apex. Laryngoscope 95(6):64–659
Koyama S, Tsubokawa T, Katayama Y, Hirota H (1991) A huge intracranial xanthogranuloma in the middle cranial fossa: case report. Neurosurgery 28(3):9–436
Jamjoom ZA, Raina V, al-Jamali A, Jamjoom AB, Yacub B, Sharif HS (1993) Intracranial xanthogranuloma of the dura in Hand-Schüller-Christian disease. Case report. J Neurosurg 78(2):297–300
Tomita H, Tamaki N, Korosue K, Kokunai T (1996) Xanthogranuloma with massive hematoma in the third ventricle: case report. Neurosurgery 39(3):4–591
Miranda P, Lobato RD, Ricoy JR, Lagares A, Ramos A (2005) Xanthogranuloma of the choroid plexus of the third ventricle: case report and literature review. Neurocirugia (Astur) 16(6):22–518
Kasliwal MK, Suri A, Rishi A, Suri V, Sharma BS, Sarkar C (2008) Symptomatic bilateral cerebellar mass lesions: an unusual presentation of intracranial xanthogranuloma. J Clin Neurosci 15(12):4–1401
Paulus W, Honegger J, Keyvani K, Fahlbusch R (1999) Xanthogranuloma of the sellar region: a clinicopathological entity different from adamantinomatous craniopharyngioma. Acta Neuropathol 97:82–377
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, Cavenee WK (2002) The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 61:215–229
Reithmeier T, Trost HA, Wolf S et al (2002) Xanthogranuloma of the Erdheim-Chester type within the sellar region: case report. Clin Neuropathol 21:8–24
Yonezawa K, Shirataki K, Sakagami Y et al (2003) Panhypopituitarism induced by cholesterol granuloma in the sellar region: case report. Neurol Med Chir (Tokyo) 43:62–259
Jung CS, Schanzer A, Hattingen E, Plate KH, Seifert V (2006) Xanthogranuloma of the sellar region. Acta Neurochir (Wien) 148:473–477
Pavón de Paz I, Peñalver Talavera D, Olivar Roldán J, Carlos Gómez-Angulo Giner J, Santonja Garriga C, Monereo Megías S (2008) Sellar xanthogranuloma. Endocrinol Nutr 55(2):102–106
Liu ZH, Tzaan WC, Wu YY, Chen HC (2008) Sellar xanthogranuloma manifesting as obstructive hydrocephalus. J Clin Neurosci 15:929–933
Sugata S, Hirano H, Yatsushiro K, Yunoue S, Nakamura K, Arita K (2009) Xanthogranuloma in the suprasellar region: case report. Neurol Med Chir(Tokyo) 49:124–127
Sulentić P, Cupić H, Cerina V, Vrkljan M (2010) Xanthogranuloma of the sellar region in a patient with sarcoidosis. Acta Clin Croat 49(1):5–61
Arai A, Nishihara M, Sasayama T, Aihara H, Hosoda K, Itoh T, Sakagami Y, Kuwamura K, Kohmura E (2010) Xanthogranuloma of the sellar region-case report. Neurol Med Chir (Tokyo) 50(6):91–488
Kamoshima Y, Sawamura Y, Motegi H, Kubota K, Houkin K (2011) Xanthogranuloma of the sellar region of children: series of five cases and literature review. Neurol Med Chir (Tokyo) 51(10):93–689
Nishiuchi T, Murao K, Imachi H, Kushida Y, Haba R, Kawai N, Tamiya T, Ishida T (2012) Xanthogranuloma of the intrasellar region presenting in pituitary dysfunction: a case report. J Med Case Rep 29;6(1):119
Kubo O, Tajika Y, Uchimuno H, Muragaki Y, Shimoda M, Hiyama H, Morishita K, Takakura K (1993) Immunohistochemical study of craniopharyngiomas. Noshuyo Byori 10(2):4–131
Le BH, Towfighi J, Kapadia SB, Lopes MB (2007) Comparative immunohistochemical assessment of craniopharyngioma and related lesions. Endocr Pathol 18(1):23–30
Zada G, Lin N, Ojerholm E, Ramkissoon S, Laws ER (2010) Craniopharyngioma and other cystic epithelial lesions of the sellar region: a review of clinical, imaging, and histopathological relationships. Neurosurg Focus 28:E4
Müller HL, Gebhardt U, Faldum A, Warmuth-Metz M, Pietsch T, Pohl F, Calaminus G, Sörensen N (2012) Xanthogranuloma, Rathke’s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare sellar malformations. J Clin Endocrinol Metab [Epub ahead of print]
Keyaki A, Hirano A, Llena JF (1989) Asymptomatic and symptomatic Rathke’s cleft cysts. Histological study of 45 cases. Neurol Med Chir (Tokyo) 29:88–93
Sumida M, Uozumi T, Mukada K, Arita K, Kurisu K, Eguchi K (1994) Rathke cleft cysts: correlation of enhanced MR and surgical findings. Am J Neuroradiol 15:525–532
Teramoto A, Hirakawa K, Sanno N, Osamura Y (1994) Incidental pituitary lesions in 1000 unselected autopsy specimens. Radiology 193:161–164
Aho CJ, Liu C, Zelman V, Couldwell WT, Weiss MH (2005) Surgical outcomes in 118 patients with Rathke cleft cysts. J Neurosurg 102:189–193
Amano K, Kawamata T, Kubo O, Hori T (2008) Long-term outcomes of surgical management for Rathke’s Cleft Cyst. J Tokyo Women’s Med Univ 78(12):519–524
Voelker JL, Campbell RL, Muller J (1991) Clinical, radiographic, and pathological features of symptomatic Rathke’s cleft cysts. J Neurosurg 74:535–544
Zhong W, You C, Jiang S, Huang S, Chen H, Liu J, Zhou P, Liu Y, Cai B (2012) Symptomatic Rathke cleft cyst. J Clin Neurosci 19(4):501–508
Sade B, Albrecht S, Assimakopoulos P, V′ezina J-L, Mohr G (2005) Management of Rathke’s cleft cysts. Surg Neurol 63:459–466
Nishioka H, Haraoka J, Izawa H, Ikeda Y (2006) Magnetic resonance imaging, clinical manifestations, and management of Rathke’s cleft cyst. Clin Endocrinol 64:184–188
Yoon JW, Jo SK, Cha DR, Cho WY, Kim HK (2001) A case of Rathke’s Cleft Cyst inflammation presenting with diabetes insipidus. Korean J Intern Med 16(2):132–135
Rosales MY, Smith TW, Safran M (2004) Hemorrhagic Rathke’s cleft cyst presenting as diplopia. Endocr Pract 10(2):129–134
Binning MJ, Liu JK, Gannon J, Osborn AG, Couldwell WT (2008) Hemorrhagic and nonhemorrhagic Rathke cleft cysts mimicking pituitary apoplexy. J Neurosurg 108(1):3–8
Chaiban JT, Abdelmannan D, Cohen M, Selman WR, Arafah BM (2011) Rathke cleft cyst apoplexy: a newly characterized distinct clinical entity. J Neurosurg 114(2):318–324
Nishioka H, Ito H, Miki T, Hashimoto T, Nojima H, Matsumura H (1999) Rathke’s cleft cyst with pituitary apoplexy: case report. Neuroradiol 41:832–834
Nakasu Y, Nakasu S, Nakajima M, Itoh R, Matsuda M (1999) Atypical Rathke’s cleft cyst associated with ossification. AJNR Am J Neuroradiol 20:1287–1289
Lee CH, Seo EK, Cho YJ, Kim SJ (2008) Large ossified Rathke’s cleft cyst—a case report and review of the literature. J Korean Neurosurg Soc 44(4):256–258
Ogawa Y, Tominaga T (2010) A partially ossified solid and cystic Rathke cleft cyst. J Neurosurg 112:1324–1326
Arai T, Horiguchi K, Saeki N, Oka H, Saito T, Takahashi-Fujigasaki J, Sakamoto H, Kato N, Dobashi H, Tanaka T, Hasegawa Y, Abe T (2011) Surgical treatment of a calcified Rathke’s cleft cyst with endoscopic extended transsphenoidal surgery-case report. Neurol Med Chir (Tokyo) 51(7):535–538
Miyajima Y, Oka H, Utsuki S, Fujii K (2011) Rathke’s cleft cyst with xanthogranulomatous change-case report. Neurol Med Chir (Tokyo) 51(10):740–742
Burt GM, Morey AL, Turner JJ, Pell M, Sheehy JP, Ho KK (2003) Xanthomatous pituitary lesions: a report of two cases and review of the literature. Pituitary 6:161–168
Nishikawa T, Takahashi JA, Shimatsu A, Hashimoto N (2007) Hypophysitis caused by Rathke’s cleft cyst. Case report. Neurol Med Chir (Tokyo) 47(3):136–139
Murakami M, Nishioka H, Izawa H, Ikeda Y, Haraoka J (2008) Granulomatous hypophysitis associated with Rathke’s cleft cyst: a case report. Minim Invasive Neurosurg 51:169–172
Nishioka H, Shibuya M, Ohtsuka K, Ikeda Y, Haraoka J (2010) Endocrinological and MRI features of pituitary adenomas with marked xanthogranulomatous reaction. Neuroradiology 52:997–1002
Noh SJ, Ahn JY, Lee KS, Kim SH (2007) Pituitary adenoma and concomitant Rathke’s cleft cyst. Acta Neurochir (Wien).149(12):1223–1228
Acknowledgments
We would like to thank Mr Takashi Sakayori for providing technical assistance and Dr Kostadin Karagiozov for his review of this manuscript.
Conflict of interest
The authors report no conflict of interest concerning the materials or methods in this study or the findings reported in this paper.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Amano, K., Kubo, O., Komori, T. et al. Clinicopathological features of sellar region xanthogranuloma: correlation with Rathke’s cleft cyst. Brain Tumor Pathol 30, 233–241 (2013). https://doi.org/10.1007/s10014-012-0130-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10014-012-0130-0